Dong-A Socio Holdings stake in ST Pharm edges up to 37.67% from 37.69% filing shows
Bitget2026/10/08 05:13Dong-A Socio Holdings’ stake in ST Pharm rose to 7,863,225 shares from 7,862,653 as of Oct. 8, 2026. Ownership edged down to 37.67% from 37.69%, reflecting a higher share count outstanding. Previously disclosed shares under major agreements fell to zero from 120,604. Filing cited open-market purchases, repayment of share-backed loans, shareholder-employee share deposits. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ST Pharm Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008000289), on October 08, 2026, and is solely responsible for the information contained therein.
- Dong-A Socio Holdings’ stake in ST Pharm rose to 7,863,225 shares from 7,862,653 as of Oct. 8, 2026.
- Ownership edged down to 37.67% from 37.69%, reflecting a higher share count outstanding.
- Previously disclosed shares under major agreements fell to zero from 120,604.
- Filing cited open-market purchases, repayment of share-backed loans, shareholder-employee share deposits.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.

Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
